Wakefield Asset Management LLLP Has $1.32 Million Holdings in Itron, Inc. (NASDAQ:ITRI)

Wakefield Asset Management LLLP increased its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 40.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,586 shares of the scientific and technical instruments company's stock after acquiring an additional 3,653 shares during the quarter. Wakefield Asset Management LLLP's holdings in Itron were worth $1,319,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Los Angeles Capital Management LLC increased its position in Itron by 15.9% in the 1st quarter. Los Angeles Capital Management LLC now owns 51,449 shares of the scientific and technical instruments company's stock worth $5,390,000 after purchasing an additional 7,058 shares during the last quarter. Jennison Associates LLC increased its position in Itron by 3.8% in the 1st quarter. Jennison Associates LLC now owns 13,972 shares of the scientific and technical instruments company's stock worth $1,464,000 after purchasing an additional 509 shares during the last quarter. Bailard Inc. increased its position in Itron by 2.8% in the 1st quarter. Bailard Inc. now owns 29,801 shares of the scientific and technical instruments company's stock worth $3,122,000 after purchasing an additional 800 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new position in Itron in the 1st quarter worth about $7,219,000. Finally, Fort Sheridan Advisors LLC increased its position in Itron by 1.8% in the 1st quarter. Fort Sheridan Advisors LLC now owns 10,988 shares of the scientific and technical instruments company's stock worth $1,151,000 after purchasing an additional 190 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.

Insider Activity

In related news, CFO Joan S. Hooper sold 938 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total value of $107,823.10. Following the sale, the chief financial officer directly owned 89,364 shares of the company's stock, valued at approximately $10,272,391.80. The trade was a 1.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP John F. Marcolini sold 3,783 shares of the business's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $116.73, for a total transaction of $441,589.59. Following the completion of the sale, the senior vice president directly owned 21,865 shares in the company, valued at approximately $2,552,301.45. This represents a 14.75% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,905 shares of company stock valued at $2,439,202. Company insiders own 1.51% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Roth Capital increased their target price on shares of Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research report on Tuesday. TD Cowen increased their target price on shares of Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a research report on Friday, June 20th. Guggenheim reissued a "buy" rating and set a $155.00 target price (up from $133.00) on shares of Itron in a research report on Monday, July 14th. JPMorgan Chase & Co. raised their target price on shares of Itron from $118.00 to $128.00 and gave the company a "neutral" rating in a research note on Tuesday. Finally, Wall Street Zen lowered shares of Itron from a "buy" rating to a "hold" rating in a research note on Sunday, June 1st. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Itron presently has an average rating of "Moderate Buy" and a consensus target price of $133.17.

Itron Stock Down 1.3%

NASDAQ ITRI opened at $134.84 on Wednesday. Itron, Inc. has a one year low of $90.11 and a one year high of $137.99. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.93 and a quick ratio of 1.65. The stock's 50 day simple moving average is $125.42 and its 200 day simple moving average is $111.69. The firm has a market cap of $6.15 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 0.86 and a beta of 1.35.

Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.22. The company had revenue of $607.15 million for the quarter, compared to analyst estimates of $608.86 million. Itron had a net margin of 10.34% and a return on equity of 19.65%. The company's revenue for the quarter was up .6% on a year-over-year basis. During the same quarter last year, the firm earned $1.24 EPS. As a group, sell-side analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.